Arexvy 58160-0882
Generic: Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted
Product NDC
58160-0882- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Kit
- Product Type
- Vaccine
- Marketing Start
- April 30, 2026
- Listing Expires
- December 31, 2027
- Application
- BLA125775
Packaging Options(1)
1 KIT in 1 CARTON (58160-882-12) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07)
External Resources